Abstract
Personalized medicine involves the co-development of both the therapeutic agent (Rx) and a companion diagnostic device (CDx), which directs a group of patients to a particular treatment. There are instances, however, when there are competing, or multiple CDx products for a given Rx. Drivers for multiple CDx products can be driven by improved efficiency, cost, novel technologies, or updated techniques over time. In these instances, concordance between the old assay (e.g., the assay used in the clinical trial or comparator companion diagnostic device in this paper) and a new assay (follow-on companion diagnostic device) needs to be assessed. Discrepancies between the old and new assays, and specifically the impact of discordance on clinical efficacy, need to be evaluated. Studies that establish similarity between two or more CDx products are called bridging studies. We provide a statistical framework for method comparison studies where there is bias in measurement of one or both assessments. We then present a simulation study to evaluate the statistical impact of an imperfect CDx on the sensitivity and specificity of the follow-on companion diagnostic device. Further, we demonstrate the influence of the CDx accuracy on clinical efficacy in the context of an enrichment clinical trial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Maitournam, A., Simon, R.: On the efficiency of targeted clinical trials. Stat. Med. 24(3), 329–339 (2005)
Li, M.J.: Statistical methods for clinical validation of follow-on companion diagnostic devices via an external concordance study. Stat. Biopharm. Res. 8(3), 355–363 (2016)
Li, M.J.: Statistical consideration and challenges in bridging study of personalized medicine. J. Biopharm. Stat. 25, 397–407 (2015)
Li, M.J., Yu, T.H., Hu, Y.F.: The impact of companion diagnostic device measurement performance on clinical validation of personalized medicine. Stat. Med. 34, 2222–2234 (2015)
Lu, Y., Dendukuri, N., Schiller, I., Joseph, L.: A Bayesian approach to simultaneously adjusting for verification and reference standard bias in diagnostic test studies. Stat. Med. 29(24), 2532–2543 (2010)
Zhou, X.-H., Obuchowski, N.A., McClish, D.K.: Statistical methods in diagnostic medicine, 2nd edn. Wiley, Hoboken (2011)
Acknowledgements
The authors gratefully thank Dr. Chang Xu from Qiagen and Dominic LaRoche from HTG Molecular Diagnostics.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Tang, SY., LaFleur, B. (2019). Challenges of Bridging Studies in Biomarker Driven Clinical Trials: The Impact of Companion Diagnostic Device Performance on Clinical Efficacy. In: Liu, R., Tsong, Y. (eds) Pharmaceutical Statistics. MBSW 2016. Springer Proceedings in Mathematics & Statistics, vol 218. Springer, Cham. https://doi.org/10.1007/978-3-319-67386-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-67386-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67385-1
Online ISBN: 978-3-319-67386-8
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)